Corcept Therapeutics, Inc. (CORT)
36.48
+1.14
(+3.23%)
USD |
NASDAQ |
Feb 24, 16:00
36.20
-0.28
(-0.77%)
After-Hours: 20:00
Corcept Therapeutics Market Cap : 3.837B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Axsome Therapeutics, Inc. | 8.568B |
| United Therapeutics Corp. | 20.38B |
| Harrow, Inc. | 1.955B |
| Ultragenyx Pharmaceutical, Inc. | 2.195B |
| Amneal Pharmaceuticals, Inc. | 4.609B |
Market Cap Related Metrics
| PE Ratio | 41.68 |
| PS Ratio | 5.884 |
| Price to Book Value | 6.073 |
| Price to Free Cash Flow | 26.83 |
| Price | 36.48 |
| Earnings Yield | 2.40% |
| Operating PE Ratio | 66.51 |
| Normalized PE Ratio | 41.68 |